Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenues | revenue | 3.69B | 4.03% |
| Income before income taxes | profit | 616.10M | 14.39% |
| Total | cost | 3.07B | 2.18% |
| Net income before noncontrolling interests | profit | 515.58M | 23.54% |
| Income tax expense (benefit) | cost | 100.52M | -17.10% |
| Policyholder benefits and claims incurred, net | cost | 1.94B | 1.85% |
| Other cost and expense, operating | cost | 970.66M | 2.18% |
| Expenses from wholly owned investees | cost | 135.84M | 7.50% |
| Interest expense, operating and nonoperating | cost | 31.71M | -0.06% |
| Net income (loss) to common stockholders | profit | 515.22M | 23.38% |
| Net income (loss) attributable to noncontrolling interest | cost | 359000 | 61.71% |
| Segment | Value | YoY |
|---|---|---|
| Insurance | 3.09B | 4.85% |
| Reinsurance and Monoline Excess | 417.53M | -4.30% |
| Others | 186.23M | 11.26% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Fixed maturity securities (amortized cost of $25,814,827 and $25,170,368; allowance for expected credit losses of $306 and $74 at march 31, 2026 and december 31, 2025, respectively) | assets | 25.51B | |
| Equity securities | assets | 1.47B | |
| Investment funds | assets | 1.40B | |
| Real estate | assets | 1.30B | |
| Arbitrage trading account | assets | 1.16B | |
| Loans receivable (net of allowance for expected credit losses of $75 and $161 at march 31, 2026 and december 31, 2025, respectively) | assets | 441.16M | |
| Total investments | assets | 31.29B | |
| Due from reinsurers (net of allowance for expected credit losses of $4,972 and $6,378 at march 31, 2026 and december 31, 2025, respectively) | assets | 3.55B | |
| Premiums and fees receivable (net of allowance for expected credit losses of $42,130 and $42,006 at march 31, 2026 and december 31, 2025, respectively) | assets | 3.47B | |
| Cash and cash equivalents | assets | 2.28B | |
| Deferred policy acquisition costs | assets | 1.01B | |
| Prepaid reinsurance premiums | assets | 870.76M | |
| Other assets | assets | 837.16M | |
| Property, furniture and equipment | assets | 567.12M | |
| Accrued investment income | assets | 246.02M | |
| Goodwill | assets | 184.33M | |
| Trading account receivables from brokers and clearing organizations | assets | 8.69M | |
| Total assets | assets | 44.32B | |
| Total liabilities | liabilities | 34.56B | |
| Cumulative effect adjustment resulting from changes in accounting principles | liabilities | 9.75B | |
| Reserves for losses and loss expenses | liabilities | 22.62B | |
| Unearned premiums | liabilities | 6.78B | |
| Senior notes and other debt | liabilities | 1.83B | |
| Other liabilities | liabilities | 1.63B | |
| Subordinated debentures | liabilities | 1.01B | |
| Due to reinsurers | liabilities | 627.76M | |
| Current and deferred federal and foreign income taxes | liabilities | 76.20M | |
| Trading account securities sold but not yet purchased | liabilities | 33000 | |
| Noncontrolling interests | liabilities | 11.07M | |
| Total stockholders’ equity | equity | 9.74B | |
| Treasury stock, value | equity | 4.64B | |
| Accumulated other comprehensive loss | equity | 601.28M | |
| Aggregate | equity | 14.98B | |
| Retained earnings | equity | 13.83B | |
| Additional paid-in capital | equity | 1.00B | |
| Common stock, par value $.20 per share: authorized 500,000,000 shares, issued and outstanding, net of treasury shares, 177,930,502 and 183,411,907 shares, respectively | equity | 158.71M |
| Item | Value |
|---|---|
| Net income (loss) to common stockholders | 515.22M |
| Increase (decrease) in liability for claims and claims adjustment expense reserve | 390.62M |
| Increase (decrease) in deferred income taxes | 77.27M |
| Increase (decrease) in unearned premiums | 47.87M |
| Realized investment gains (losses) | 15.78M |
| Increase (decrease) in reinsurance recoverable | 15.25M |
| Share-based payment arrangement, noncash expense | 13.23M |
| Net income (loss) attributable to noncontrolling interest | 359000 |
| Increase (decrease) in debt securities, trading, and equity securities, fv-ni | -7.04M |
| Increase (decrease) in deferred policy acquisition costs | -10.38M |
| Depreciation and (accretion) amortization | -15.47M |
| Income (loss) from equity method investments, net of dividends or distributions | -39.53M |
| Increase (decrease) in premiums receivable | -48.65M |
| Other | -286.67M |
| Item | Value |
|---|---|
| Proceeds from maturities and prepayments of fixed maturity securities | 1.36B |
| Proceeds from sale of fixed maturity securities | 271.60M |
| Increase (decrease) in broker-dealer related receivables (payables), net, investing activities | 157.99M |
| Payments to acquire property, plant, and equipment, net | 27.67M |
| Proceeds from sale of equity securities, available-for-sale | 4.57M |
| (contributions to) distributions from investment funds | -4.03M |
| Payments for (proceeds from) loans receivable | -30.58M |
| Payments for (proceeds from) real estate | -37.43M |
| Payments to acquire equity securities, available-for-sale | -120.52M |
| Payments to acquire debt securities, available-for-sale | -2.22B |
| Item | Value |
|---|---|
| Net proceeds from issuance of debt | 1.10M |
| Proceeds from (payment for) other financing activity | -4.08M |
| Payments of ordinary dividends, common stock | -33.70M |
| Payments for repurchase of common stock | -302.43M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 2.54B |
| Cash and cash equivalents, end of period | 2.28B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support